Appointment of Non-Executive

T&F Informa PLC
27 August 2004

27 August 2004

                                T&F Informa plc

                    Appointment of Non-Executive Director

T&F Informa plc, a leading provider of high value, specialist information to the
academic, professional and commercial markets, announced today the appointment
of Pamela J. Kirby PhD as a Non-Executive Director of the company with effect
from 1 September 2004.

Dr Kirby (50) is currently a Non-Executive Director of Smith and Nephew plc and
Oscient Pharmaceuticals Corporation. She was previously CEO of US based
Quintiles Transnational Corporation, a  provider of product development and
commercial services to the pharmaceutical and biotechnology industries. Prior to
joining Quintiles, Dr Kirby held various senior positions in the pharmaceutical
industry at Astra AB (now AstraZeneca PLC), British Biotech plc (now Vernalis
plc) and F. Hoffmann-La Roche Limited. Dr Kirby has a PhD in Clinical
Pharmacology from the University of London.

Commenting on the appointment David Smith, Chairman of T&F Informa said:

'Pam brings a great deal of business and corporate experience to the team,
especially in the high growth life sciences and pharmaceutical markets where the
enlarged group has significant positions and products. She also has strong
experience in international markets.'


                                      ENDS

For further information, please contact:

T&F Informa plc                                         020 7017 5000
David Smith, Chairman

Financial Dynamics                                      020 7831 3113
Tim Spratt / Charles Palmer




                      This information is provided by RNS
            The company news service from the London Stock Exchange